Colestyramine Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
10
Total Quantity
412
NHS Cost
£101
vs National Avg
-65.3%
MAPLE ACCESS PARTNERSHIP LLP prescribed 10 items of Colestyramine over the last 12 months at a cost of £101 to the NHS. This is 65.3% below the national average prescribing rate. Colestyramine is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 10 |
|---|---|
| Total Quantity | 412 |
| Total NHS Cost | £101 |
| Presentations | 2 different forms |
| vs National Average | -65.3% |
Colestyramine Prescribing Comparison
| This practice | 10 items |
|---|---|
| National average per practice | 29 items |
| Difference | -65.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.